Loading quotes...
Forecast
| Buy |
1 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
The Cannabist Company sells Virginia business to Curaleaf for $110 million
The Cannabist Company is selling its cannabis business in Virginia to a Curaleaf subsidiary for $110 million ( $80 million in cash, $20 million deferred, $10 million Schuldschein bearing 6% interest). The deal includes five active retail locations, one in development, and roughly 82,000 square feet of cultivation and production space near Richmond, and substantially exceeds the company’s current market capitalization. A special committee is reviewing additional strategic options; part of the proceeds will be used to repay outstanding notes. Closing is expected in early 2026, subject to regulatory approvals and a 15-day go-shop period. » More on de.investing.com
Cannabist Company reports revenue decline and falling EBITDA in Q3 2025
Cannabist Company posted a 7.5% revenue decline to $80m in Q3 2025 and adjusted EBITDA fell from $8.5m to $3m. Wholesale revenue contracted sequentially by 20%. Despite the weakness, the company generated positive free cash flow of $2.3m and ended the quarter with $17.8m in cash. Management formed a special committee to review strategic alternatives including asset sales and mergers; at the same time the company exited Florida and sold three locations in Pennsylvania while opening two new shops in Ohio. » More on de.investing.com
Cannabist Company reports revenue decline and share price loss due to restructuring
Cannabist Company Holdings Inc. reported a slight revenue decrease to 87 million US dollars and a lower gross margin for the second quarter of 2025, as the company undergoes a comprehensive restructuring and withdraws from several markets. Despite an improved EBITDA margin and a focus on core markets, the share price fell by 8.79% following the announcement of the results. Management emphasized the priority of cost savings and operational efficiency, but continues to face risks such as market saturation and regulatory changes. » More on de.investing.com
Financials
| (EUR) | September 2025 | YoY |
|---|---|---|
| Revenue | 68.1m | - |
| Gross profit | 19.52m | - |
| Net profit | -12.15m | - |
| EBITDA | 6.65m | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €12.92m |
Number of shares | 497.46m |
52-week high/low | €0.14 - €0.0178 |
| Dividends | No |
Beta | 1.05 |
P/E ratio | -0.15 |
PEG ratio | 0.00 |
P/B ratio | -0.10 |
P/S ratio | 0.09 |
Company profile
The Cannabist Company Holdings Inc. engages in the cultivation, manufacture, and provision of cannabis products and related services in the United States and internationally. The company offers spanning flower, edibles, oils, and tablets under the Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brand names. It holds licenses in 17 jurisdictions in the United States. The company was formerly known as Columbia Care Inc. and changed its name to The Cannabist Company Holdings Inc. in September 2023. The company was founded in 2012 and is headquartered in New York, New York.
| Name | Cannabist Co. Holdings Aktie |
| CEO | Christopher Marr |
| Headquarters | Malvern,
pa USA |
| Website | |
| IPO | 29/04/2019 |
| Employees | 2,829 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Neo | CBST.NE |
Pnk | CBSTF |
Frankfurt | VW5.F |
Düsseldorf | VW5.DU |
München | VW5.MU |